TKNO

TKNO

Alpha Teknova Inc

Alpha Teknova Inc manufactures critical reagents and media for biological research, drug discovery, and molecular diagnostics. Its products support pharmaceutical and biotech companies, contract manufacturers, and academic institutions in developing therapies and vaccines.

⚕️ Healthcare NASDAQ Listed 2021 $ USD
$1,000 invested 5 years ago $377today

Score Overview

1 Year
Score
Net Growth2.84%
Net TrendGrew
Net Income Consistency
Rev Growth7.85%
Rev TrendGrew
Revenue Consistency
5 Years
Score5.5
Net Growth-71.06%
Net Trend80%
Net Income Consistency
Rev Growth18.45%
Rev Trend80%
Revenue Consistency
All Time
Score
Net Growth-71.06%
Net Trend80%
Net Income Consistency
Rev Growth18.45%
Rev Trend80%
Revenue Consistency

See the full market ranking →

Alpha Teknova Inc fundamental performance

Between 2021 and 2025, revenue grew from $ 36M to $ 40M and net income went from -$ 9M to -$ 17M. Revenue increased in 80% of the years measured; net income in 80%.

Alpha Teknova Inc currently holds a 5-year HDB Score of 5.5 out of 10. How the HDB Score is calculated.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 7.39
1 Year2025-08-12
$ 4.7854.60%
5 Years2021-08-12
$ 19.60-62.30%
All Time2021-06-25
$ 25.00-70.44%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 43M-$ 16M$ 17M
2025$ 40M-$ 17M$ 5M
2024$ 37M-$ 26M$ 30M
2023$ 36M-$ 36M$ 28M
2022$ 41M-$ 47M$ 42M
IPO2021$ 36M-$ 9M$ 87M

Explore beyond TKNO

You're looking at Alpha Teknova Inc. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies